Matches in Wikidata for { <http://www.wikidata.org/entity/Q60203634> ?p ?o ?g. }
- Q60203634 description "article scientifique publié en août 2010" @default.
- Q60203634 description "artículu científicu espublizáu n'agostu de 2010" @default.
- Q60203634 description "im August 2010 veröffentlicher wissenschaftlicher Artikel" @default.
- Q60203634 description "scientific article published on 23 August 2010" @default.
- Q60203634 description "wetenschappelijk artikel" @default.
- Q60203634 description "наукова стаття, опублікована в жовтні 2010" @default.
- Q60203634 name "Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple m" @default.
- Q60203634 name "Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple m" @default.
- Q60203634 type Item @default.
- Q60203634 label "Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple m" @default.
- Q60203634 label "Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple m" @default.
- Q60203634 prefLabel "Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple m" @default.
- Q60203634 prefLabel "Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple m" @default.
- Q60203634 P1433 Q60203634-A9F7E3F9-2ABD-4E3F-8DF9-8AB3C4D3D960 @default.
- Q60203634 P1476 Q60203634-B0BF741F-725A-49C5-BDC4-4A53FF672CD2 @default.
- Q60203634 P2093 Q60203634-199AF495-8D2E-4C08-B272-B5736356096B @default.
- Q60203634 P2093 Q60203634-2A0CC20D-EF9C-40CB-BCE1-AE28220AE848 @default.
- Q60203634 P2093 Q60203634-5E8F611C-7ECC-4C31-ACB4-8FAFEF56B6EE @default.
- Q60203634 P2093 Q60203634-8B1B0580-6AFA-4CFD-8735-63AFBC7A5F20 @default.
- Q60203634 P2093 Q60203634-CDCA1BB8-7B99-406E-8284-E401D4E365F9 @default.
- Q60203634 P2093 Q60203634-EB360E0D-13DD-48DF-9263-36F12D8237BD @default.
- Q60203634 P2860 Q60203634-100D46D2-824C-4286-B3D0-DC6E041B67CD @default.
- Q60203634 P2860 Q60203634-10522CB8-B64E-4CAF-B4C2-077F9C4F7B27 @default.
- Q60203634 P2860 Q60203634-300B9EC2-6AC9-4A99-A77F-BDF3211E01A2 @default.
- Q60203634 P2860 Q60203634-38B72818-7DAA-4850-A964-8B7498318D35 @default.
- Q60203634 P2860 Q60203634-39FB9E22-F12A-4091-8BEF-70A4B41BDF2E @default.
- Q60203634 P2860 Q60203634-53100612-2E9C-4D5D-8053-7E3C6FF5E0C1 @default.
- Q60203634 P2860 Q60203634-5626F142-12A4-44E9-B51F-297BEF2AE72C @default.
- Q60203634 P2860 Q60203634-5E02D0D9-B247-4FF6-9E7F-269854352ACC @default.
- Q60203634 P2860 Q60203634-64DE399F-EAA6-430C-B3BC-3F5BDA510902 @default.
- Q60203634 P2860 Q60203634-6CFF2CDE-1FE6-480E-A94E-1306B2A84488 @default.
- Q60203634 P2860 Q60203634-8941B230-7630-4018-83C3-4FACBBC0081B @default.
- Q60203634 P2860 Q60203634-92199BFF-0203-4A24-A548-6B237E86AB1D @default.
- Q60203634 P2860 Q60203634-925F8910-6333-4226-B7B4-920BDDD58F15 @default.
- Q60203634 P2860 Q60203634-A4E3D49A-DD58-43C9-B22D-EBA4BA66D71C @default.
- Q60203634 P2860 Q60203634-B67885F4-A8A2-40C8-92C2-53BF1D4AA47F @default.
- Q60203634 P2860 Q60203634-C107BFCD-7B80-436E-A19E-251528D99783 @default.
- Q60203634 P2860 Q60203634-CB21ACDF-5819-4E32-B9C5-66AE795AC5FE @default.
- Q60203634 P2860 Q60203634-CB259FCD-FD26-4AC4-812B-B98E1988FEE3 @default.
- Q60203634 P2860 Q60203634-D5551300-E1DE-4138-84C6-8C4A7DDB6A16 @default.
- Q60203634 P2860 Q60203634-D8159DD9-E8FA-4675-ADD8-930493CE1D37 @default.
- Q60203634 P2860 Q60203634-E97A894F-EB85-4562-B453-C38C2756D894 @default.
- Q60203634 P2860 Q60203634-EC262AA0-D29F-48AD-972D-BD525CF8801B @default.
- Q60203634 P304 Q60203634-D1883A7A-0FAA-4124-848B-D49F55EE8919 @default.
- Q60203634 P31 Q60203634-71CE3FEB-D5BE-4731-92D9-95085042DEAE @default.
- Q60203634 P356 Q60203634-D3AE7205-15B5-4C50-8C3B-6C76A862FAC7 @default.
- Q60203634 P433 Q60203634-BEE76932-D394-4DD9-A7CD-B1A423283D24 @default.
- Q60203634 P478 Q60203634-FABBDDDA-C8C5-4937-B0B4-8CBDFFF7D339 @default.
- Q60203634 P50 Q60203634-00660CBD-A436-44EC-808B-A4480F304D69 @default.
- Q60203634 P50 Q60203634-05D574E8-0242-4A5F-A26A-3471C4C93429 @default.
- Q60203634 P50 Q60203634-32A03570-B947-4D4C-A19B-2562A525AB93 @default.
- Q60203634 P50 Q60203634-396CB309-9213-49E0-8BCC-7F53D2645959 @default.
- Q60203634 P50 Q60203634-39E74A2C-0463-4285-8DAD-2AD2CAEF6205 @default.
- Q60203634 P50 Q60203634-3B654FF3-87E7-44B9-A7EB-D2A066B63858 @default.
- Q60203634 P50 Q60203634-44CF6216-A413-4DF7-AA6F-01F3C0E20BB0 @default.
- Q60203634 P50 Q60203634-4BFE1A17-819E-4FB8-A762-7A242A53D366 @default.
- Q60203634 P50 Q60203634-4F45DC06-EF9B-4CA3-BE4A-A2E20CC521C7 @default.
- Q60203634 P50 Q60203634-503E864D-717E-45E5-9010-FB4B651C2ACB @default.
- Q60203634 P50 Q60203634-508ECC2E-4977-4725-83A0-3B1DA5359592 @default.
- Q60203634 P50 Q60203634-6254D45A-53DC-4F83-893C-ACE1FB8C6338 @default.
- Q60203634 P50 Q60203634-69BD027F-87E6-48FE-B04C-650CD0C2CE22 @default.
- Q60203634 P50 Q60203634-78BC9B15-65C4-4A13-A15B-CC8F3470720A @default.
- Q60203634 P50 Q60203634-78FF5C7E-6072-4A28-B548-5FFFE5B5D8CA @default.
- Q60203634 P50 Q60203634-79884E02-957B-4CC0-B778-3B5774A8B955 @default.
- Q60203634 P50 Q60203634-95C1720B-9DC4-4C9A-BB62-49812C04F4B3 @default.
- Q60203634 P50 Q60203634-A4DC3A71-EBF7-4268-9680-C6F25A29A83D @default.
- Q60203634 P50 Q60203634-AE7E6E3D-6D06-4658-8DD4-035E49F6087A @default.
- Q60203634 P50 Q60203634-D6783A13-1211-4B08-A4FD-5255881AED2C @default.
- Q60203634 P50 Q60203634-E06504C0-E459-4C89-A50D-762B5B218D33 @default.
- Q60203634 P50 Q60203634-FA95819A-6135-44FD-9AE3-C09B6354BD89 @default.
- Q60203634 P50 Q60203634-FF7E0C4E-2209-4B34-844B-DD663486CC70 @default.
- Q60203634 P577 Q60203634-E45A3631-DAF3-4BF0-802C-D5F75A685DAE @default.
- Q60203634 P698 Q60203634-C2C0485D-B0DD-461E-8AB5-047F526CCF77 @default.
- Q60203634 P356 S1470-2045(10)70187-X @default.
- Q60203634 P698 20739218 @default.
- Q60203634 P1433 Q13747613 @default.
- Q60203634 P1476 "Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial" @default.
- Q60203634 P2093 "Alejandro Martín" @default.
- Q60203634 P2093 "Francisco-Javier Peñalver" @default.
- Q60203634 P2093 "Jose-Mariano Hernández" @default.
- Q60203634 P2093 "Luis Palomera" @default.
- Q60203634 P2093 "Raquel de Paz" @default.
- Q60203634 P2093 "Yolanda González" @default.
- Q60203634 P2860 Q28252396 @default.
- Q60203634 P2860 Q33680252 @default.
- Q60203634 P2860 Q34307206 @default.
- Q60203634 P2860 Q34753416 @default.
- Q60203634 P2860 Q34815786 @default.
- Q60203634 P2860 Q36941047 @default.
- Q60203634 P2860 Q36969778 @default.
- Q60203634 P2860 Q37268930 @default.
- Q60203634 P2860 Q39361121 @default.
- Q60203634 P2860 Q43048164 @default.
- Q60203634 P2860 Q43109172 @default.
- Q60203634 P2860 Q43195076 @default.
- Q60203634 P2860 Q46006794 @default.
- Q60203634 P2860 Q46068547 @default.
- Q60203634 P2860 Q46094234 @default.
- Q60203634 P2860 Q46573449 @default.
- Q60203634 P2860 Q46985882 @default.